BunnyRayRay
Set a live reminder
[Synopsis]
With the global market transitions since the start of 2024, how can an active investor possibly capture these pivotal turns and evolutions for their investment strategy? With the final live webinar for our mid-year funds series, learn how investors like yourselves can potentially leverage on Income strategies to navigate the changes on a global scale with our experts from PIMCO and Moomoo Singapore. Join us and you may be rewarded with qu...
With the global market transitions since the start of 2024, how can an active investor possibly capture these pivotal turns and evolutions for their investment strategy? With the final live webinar for our mid-year funds series, learn how investors like yourselves can potentially leverage on Income strategies to navigate the changes on a global scale with our experts from PIMCO and Moomoo Singapore. Join us and you may be rewarded with qu...
A Pivotal Year: Strategies for Capturing Income
Jun 28 17:00
24
3
BunnyRayRay
liked
$Gilead Sciences (GILD.US)$ $Myovant Sciences (MYOV.US)$
$Disney (DIS.US)$ $Myovant Sciences (MYOV.US)$
3 reasons to consider MYOV after taking profit
1) great fundamentals - great leaps in price to sales ratio (value) and also enterprise value to EBITA (growth) Q to Q
a) 2 approved life saving/changing blockbusters and more pending. Not going into technical but manydoctors and client attested to the benefits and the increasing scripts speaks of itself
b) strong financials - huge cash runway of $6b+ cash for a $1.4b market capital company with incoming streams of income from tiered payments and commercialising sales of 2 great products
c) Experienced Pfizer commercialising the above drugs.. acknowledging the value with 4.2b tiered payment.. Pfizer taking this on also speaks volume andthe confidence in the 4.2b price for 50%
2) Buyout Target for Sumi who is facing a patent cliff and can fully own last of the “vant” company or secondary contender PFizer who is flooded with cash and looking to buy. Lots of M&A happening in this space.
3)Fantastic Value and looking at a reversal trend. Cyclical move into biomed.. great oppty and timing for the buyout before price become higher…and short squeeze due to manupulation of the bullies in a Low float enviroment… through observation of the capital flow trends and also price movements
$Disney (DIS.US)$ $Myovant Sciences (MYOV.US)$
3 reasons to consider MYOV after taking profit
1) great fundamentals - great leaps in price to sales ratio (value) and also enterprise value to EBITA (growth) Q to Q
a) 2 approved life saving/changing blockbusters and more pending. Not going into technical but manydoctors and client attested to the benefits and the increasing scripts speaks of itself
b) strong financials - huge cash runway of $6b+ cash for a $1.4b market capital company with incoming streams of income from tiered payments and commercialising sales of 2 great products
c) Experienced Pfizer commercialising the above drugs.. acknowledging the value with 4.2b tiered payment.. Pfizer taking this on also speaks volume andthe confidence in the 4.2b price for 50%
2) Buyout Target for Sumi who is facing a patent cliff and can fully own last of the “vant” company or secondary contender PFizer who is flooded with cash and looking to buy. Lots of M&A happening in this space.
3)Fantastic Value and looking at a reversal trend. Cyclical move into biomed.. great oppty and timing for the buyout before price become higher…and short squeeze due to manupulation of the bullies in a Low float enviroment… through observation of the capital flow trends and also price movements
7
BunnyRayRay
liked
$Boeing (BA.US)$ Qantas and Singapore Airlines have decided to buy Airbus, which is not good news for Boeing.
Translated
27
2
BunnyRayRay
liked
$SGX (S68.SG)$ Waiting.
Translated
28
BunnyRayRay
liked
$Netflix (NFLX.US)$ Netflix on Tuesday announced steep price cuts of up to 60% in India, Aims to regain market share from $Amazon (AMZN.US)$ and $Disney (DIS.US)$. The company said in a statement on Tuesday that it had cut prices on all of its four-tier packages, with the biggest reduction coming from 499 rupees to 199 rupees ($2.60) a month for the entry-level package. The new price will make streaming services more accessible to Indian viewers.
12
1
BunnyRayRay
liked
Market Snapshot:
The stock market's rapid rebound is good news for ETF traders who've sunk a record $1.5 billion on a high-octane tech bet.
With the $NASDAQ 100 Index (.NDX.US)$ surging on Tuesday and Wendsday, it looks like vindication for investors who poured into the $ProShares UltraPro QQQ ETF (TQQQ.US)$ en masse in the Friday rout.
Quote of the day:
Someone's sitting in the shade today because someone planted a tree a long time ago. - Warrem Buffett
$Nasdaq (NDAQ.US)$ $S&P 500 Index (.SPX.US)$ $Dow Jones Industrial Average (.DJI.US)$
The stock market's rapid rebound is good news for ETF traders who've sunk a record $1.5 billion on a high-octane tech bet.
With the $NASDAQ 100 Index (.NDX.US)$ surging on Tuesday and Wendsday, it looks like vindication for investors who poured into the $ProShares UltraPro QQQ ETF (TQQQ.US)$ en masse in the Friday rout.
Quote of the day:
Someone's sitting in the shade today because someone planted a tree a long time ago. - Warrem Buffett
$Nasdaq (NDAQ.US)$ $S&P 500 Index (.SPX.US)$ $Dow Jones Industrial Average (.DJI.US)$
28
1
3